At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02627 AB&B BIO-TECH-B
Trading 03-20 14:22:41
38.720
-0.420
-1.07%
High43.500
Low38.500
Vol883.00K
Open43.500
D1 Closing39.140
Amplitude12.77%
Mkt Cap15.22B
Tradable Cap11.48B
Total Shares393.00M
T/O35.06M
T/O Rate0.30%
Tradable Shares296.36M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
AB&B BIO-TECH-B (02627) Schedules 31 Mar 2026 Board Meeting to Approve FY2025 Audited Results and Consider Final Dividend
Ab&B Bio Tech Co Ltd JS is a China-based company primarily engaged in the research, development, manufacturing, and commercialization of vaccines. Its product pipeline includes two core products, the quadrivalent subunit influenza vaccine and lyophilized human rabies vaccine candidate, along with 11 other vaccine candidates. The Company primarily operates within the domestic market.